The cytotoxicity and biochemical effects of several marketed antibiotics on four mammalian cell lines were determined. 
Materials.
The labeled precursors; [Methyl-3H] thymidine (2.2 Ci/mmole), [5-3H] uridine (27 Ci/mmole) and DL(l-14C) leucine (40-60 mCi/mmole) were purchased from New England Nuclear, Boston, Massachusetts. RPMI 1629 and 1634 media were supplied by Associated Biomedic Systems, Inc., Buffalo, New York. EAGLE'S basal medium (BME) was obtained from Microbiological Associates, Bethesda, Maryland.
Mammalian Cell Growth in Culture. The basal media for growing mouse leukemic L1210 cells, human acute myelogenous leukemia RPMI 6410 and human lymphocyte were RPMI 1634 with 5% fetal calf serum (FCS)", RPMI 1634 with 10% FCS", and RPMI 1629 with 10% FCS and 1% human serum (a modification of GLICK et al.3), respectively. Sodium bicarbonate (0.075%), penicillin (0.1 mg/ml of medium), and streptomycin (50 ug/ml of medium) were added to each of the basal media. KB cells were cultured in BME with 10% FCS, bacitracin (100 ug/ml), streptomycin (100 ,cog/ml), and peptone (500 µg/ml)4). Cells used for the experiments were incubated at 37°C in the logarithmic phase of growth.
Growth Inhibition Studies. For KB cells, 3.8 ml of cell suspension (approximately 2.5 x 104 cells/ml) and 0.2 ml of drug were pipetted in plastic culture tubes with screw caps (16 mm x 125 mm; Falcon Plastic Co., Oxnard, California). After 3 days incubation, the medium was decanted and cells were detached with 0.05 trypsin (10 min). Cells were counted with a Coulter counter (Coulter Electronics, Hialeah, Florida). For the other three cell lines, 4 nil of cell suspension (approx. 5 x 103 cells/ml for L1210 cells and 1 x 104 cells/ml for either RPM[ 6410 or RPMI 1788) were incubated with I ml of drug or solvent for 3 days and cell number was determined. The ID50 (concentration for 50% inhibition of cell growth) was calculated".
For time-course studies, either RPMI 6410 or RPMI 1788 (approx. 5 x 105 cells/ml) was incubated with drug for 4 and 24 hours, following which the cells were washed twice and then resuspended in fresh medium at a concentration of 1 x 10 cells/ml. Cells were counted after 3 days growth.
L1210 Cell Survival Studies. The cloning method for determining cell survival has been described5). In all cases we used duplicate cultures per sample and cells in exponential growth at the time of drug exposure. Briefly, drugtreated L1210 cells were centrifuged, washed, and resuspended at 105 cells/mi. The cells were serially diluted in medium, and the final dilution was made in RPMI 1634 medium containing 20% serum and 0.15 '' agar. Cells were dispensed into three culture tubes per sample and incubated for 8 -10 days, following which colonies were visually counted. To calculate percentage survivals, the control (no drug treatment) samples were normalized to 1000. survival. The coefficient of variation in determining cell survival was about 15%, , the coefficient of variation being the standard deviation expressed as a percentage of the mean.
Macromolecular Synthesis.
The procedure used in this study has been described1). The specific activity for incorporation of a labeled metabolite was expressed as cpm/106 cells.
For the time-course studies, RPMI 6410 cells (approx. 5 x 105 cells/ml) were incubated with drug for 4 and 24 hours. The drug was then removed by centrifugation, cells were washed twice and resuspended in fresh medium. The cells were incubated with labeled metabolite for 40 minutes, following which the radioactivity was determined.
Results

Inhibition of Mammalian Cell Growth by Antibiotics and Antitumor Drugs
In view of the results (Table 1) , we considered the antibiotic to be growth inhibitory when the ID50 was less than 0.4 uomole/ml. The results indicate that tetracycline was the most inhibitory antibiotic towards cell growth, followed by clindamycin and erythromycin. Cephaloglycin was much more growth inhibitory to KB and RPMI 1788 than to RPMI 6410. Chloramphenicol was much more inhibitory towards L1210 cells, but was nontoxic to all three human cell lines. The reasons for these differences remain obscure. Ampicillin, lincomycin, and penicillin G did not significantly inhibit any of the four mammalian cell lines (ID50 > 0.4 umole/ml).
Of the clindamycin metabolites ( Fig. 1) , N-demethyl clindamycin was as active as clindamycin ( (Table 3) .
Of the clindamycin metabolites, N-demethyl clindamycin was the only cytotoxic compound (Table 3) . Clindamycose, clindamycin sulfoxide, and N-demethyl clindamycin sulfoxide, N-demethyl lincomycin, and lincomycin were not lethal (>90% survival at 2 umole/ml) . 
days (37°C). t Repeated twice .
A probable metabolite although it has not been isolated in the biological systems. thesis was measured immediately after the removal of drug. The results (Table 4) indicate that neither macromolecular synthesis nor growth of RPMI 6410 cells was inhibited after a 24-hour incubation with 0.23 umole/ml clindamycin, but both synthesis and growth remained inhibited after a 4-hour incubation with higher drug concentration (1.08 /role/ml).
The inhibitory effects of tetracycline were apparent when cells were exposed to 0.023 umole/ml drug for 24 hours. At 0.12 umole/ml, the drug effects were irreversible after a 4-hour incubation. Clearly, the inhibitory effects exhibited by both drugs were dose and time dependent, and their effects on macromolecular synthesis closely correlated with the growth inhibition as illustrated in Table 4 . Drug was removed after a 4-or 24-hour incubation with the cells. For growth-inhibition studies, cell numbers were determined at the end of 72 hours (total incubation time). Average of triplicate samples.
For macromolecular synthesis, a pulse labeling (40 min) with radioactive thymidine, uridine, or leucine was immediately followed by the removal of drug.
Discussion
In 1959, SMITH et al4) described the cytotoxic effect of several antibiotics including chloramphenicol and tetracycline on human KB cells in culture. Recently, DONTA7) reported that clindamycin at 10 ug/ ml (0.022 /oriole/ml) or higher concentrations markedly impaired the DNA synthesis of various functional mammalian tumor cells, and suggested that clindamycin might have potential use as an anticancer agent. We decided to evaluate this possibility using four mammalian cell lines; namely, mouse leukemia L1210, human KB, human lymphocyte RPMI 1788, and human acute myelogenous leukemia RPMI 6410. Several marketed antibiotics and metabolites of clindamycin6,8) were included in this study. Cytotoxic effects were measured both by inhibition of cell growth and cell-kill and biochemical effects were determined by the inhibition of DNA, RNA, and protein synthesis. Several clinically useful anticancer drugs were also included in this study for comparison purposes.
Our studies showed that tetracycline, erythromycin, clindamycin, and cephaloglycin were cytotoxic (ID50 <0.4 umole/ml).
In contrast, ampicillin, penicillin G, and lincomycin were not. Of the clindamycin metabolites, only N-demethyl clindamycin was as cytotoxic as clindamycin (Tables I and  3 ). The metabolic transformations at the anomeric center (R) of a-D-galactopyranoside ( Fig. 1) (Tables 1 and 3) . These results clearly indicate that the substitution (R=-SCH) of anomeric center of a-D-galatopyranoside moiety of clindamycin was necessary for its cytotoxicity towards these mammalian cells. A similar association with antimicrobial activity was reported elsewhere".
By and large, none of the antibiotics tested approached the cytotoxic effect of several classes of clinically useful anticancer drugs on three mammalian cell lines (Table 2) . Although the cytotoxic effects of tetracycline approached those of hydroxyurea, tetracycline has not been known to be an effective anticancer drug.
Therefore, the potential for developing these antibiotics, including clindamycin as suggested by DONTA, as anticancer agents is not very promising unless some other merits could be demonstrated. It was of interest that both L1210 cells and RPMI 6410 were strikingly more sensitive to 5-fluorodeoxyuridine (850-2,500 times) than RPMI 1788 cells. Also, both cell lines were more sensitive (3-6 times) to 5-fluorouracil than RPMI 1788. Whether this difference reflects a difference in metabolism of these two drugs by the three cell lines is not known.
Whether DNA synthesis inhibition is important in the pathogenesis of clindamycin-associated colitis10) as suggested by DONTA", remains an issue to be resolved. Although ampicillin and lincomycin have been reported to be associated with pseudomembranous colitis11), the drugs, in our hand have not been found to be very cytotoxic towards mammalian cells (Tables 1 and 3 ). DONTA's study did not show whether the inhibition of DNA synthesis by clindamycin was reflected in the inhibition of cell growth. Furthermore, clindamycin was about 50-times more inhibitory towards the DNA synthesis of mammalian tumor cells used by DONTA than towards those of RPMI 6410 (Table 4) Recently, ALPERS and GRIMME12) reported the effects of clindamycin and its metabolites on DNA synthesis of rabbit colon maintained in organ culture.
Clindamycose was found to be inhibitory in their system but was inactive in our tests. Although N-demethyl clindamycin was most inhibitory, the effects were generally reversible. No conclusion could be drawn from their study whether the pathogenesis of pseudomembranous colitis correlated with the transient biochemical effects observed.
